Please login to read the full article.
Scrip Regulatory Affairs
US FDA SOP seeks to convey new regulatory expectations to medtech firms faster
22 July 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA proposes revised criteria for accepting only "complete" device submissions
- US FDA sets 30 June deadline for finalising companion diagnostics guidance; publishes other device priorities
- US FDA explains processes to appeal against decisions of its device staff
- US FDA tackles inconsistency in requests for additional data by medtech review staff
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
